Image
Aimovig® (erenumab) hero image showing a man in a meeting.
Image
Aimovig® (erenumab) hero image showing a woman and a man in a meeting.

Aimovig injection training video

This page is specifically intended to support patients who have been prescribed Aimovig (erenumab) by a UK healthcare provider. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.

2098980_Aimovig_DR2 (1) VIDEO

More information about Aimovig

Great Britain (GB) Summary of Product Characteristics (SmPC) for Aimovig


Great Britain (GB) Patient Information Leaflet (PIL) for Aimovig

These links will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.

Northern Ireland (NI) Summary of Product Characteristics (SmPC) for Aimovig

Northern Ireland (NI) Patient Information Leaflet (PIL) for Aimovig

These links will take you to the electronic medicines compendium (emc) Northern Ireland website, which is a non-Novartis website.


UK | October 2024 | FA-11294062

Reporting side-effects

If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. You can report side-effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side-effects you can help provide more information on the safety of your medication.